BRONCHODILATOR AND TOCOLYTIC FEATURES OF β2-ADRENOCEPTOR AGONISTS

The issues (aspects) of bronchodilator and tocolytic actions of β₂-adrenoceptor agonists are reviewed. The data on short-acting and new long-acting β₂-agonists are presented. It is marked that it is necessary to use long-acting β₂-agonists and glucocorticosteroids concomitantly. Examples of clinical...

Full description

Saved in:
Bibliographic Details
Published inRazrabotka i registraciâ lekarstvennyh sredstv (Online) no. 1; pp. 182 - 186
Main Authors S. Ya. Skachilova, E. V. Shilova, V. M. Pavlov, T. N. Molostova
Format Journal Article
LanguageRussian
Published LLC Center of Pharmaceutical Analytics (LLC «CPHA») 01.01.2019
Subjects
bronchodilator and tocolytic features of β2-adrenoceptor agonists
clinical efficacy
glucocorticosteroids
short-acting and long-acting medicines
Online AccessGet full text

Cover

More Information
Summary:The issues (aspects) of bronchodilator and tocolytic actions of β₂-adrenoceptor agonists are reviewed. The data on short-acting and new long-acting β₂-agonists are presented. It is marked that it is necessary to use long-acting β₂-agonists and glucocorticosteroids concomitantly. Examples of clinical efficacy of locally produced β₂-adrenoceptor agonist salbutamol hemisuccinate in various dosage forms used as a bronchodilator for treatment of bronchopulmonary diseases, and also as a tocolytic for habitual noncarrying of pregnancy are given.
ISSN:2305-2066
2658-5049